{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T03:24:45Z","timestamp":1765423485130},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,14]]},"DOI":"10.7759\/cureus.54219","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T06:43:31Z","timestamp":1707979411000},"source":"Crossref","is-referenced-by-count":1,"title":["Transient Abnormal Myelopoiesis: An Abnormal Course and the Efficacy of Delayed Treatment"],"prefix":"10.7759","author":[{"given":"Purbasha","family":"Mishra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Fajrudheen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanushree","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tapas Kumar","family":"Som","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandhya","family":"Biswal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Chhabra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Nelson Textbook of Pediatrics. 21st Ed","author":"Kliegman RM","year":"2019","unstructured":"Kliegman RM, Geme JS. Nelson Textbook of Pediatrics. 21st Ed. Elsevier, Philadelphia, PA; 2019."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)05264-2","article-title":"Risks of leukemia and solid tumours in individuals with Down's syndrome","volume":"355","author":"Hasle H","year":"2000","unstructured":"Hasle H, Clemmensen IH, Mikkelsen M. Risks of leukemia and solid tumours in individuals with Down's syndrome. Lancet. 2000, 355:165-9. 10.1016\/S0140-6736(99)05264-2","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.31442","article-title":"Hematological abnormalities during the first week of life among neonates with Down syndrome: data from a multihospital healthcare system","volume":"143A","author":"Henry E","year":"2007","unstructured":"Henry E, Walker D, Wiedmeier SE, Christensen RD. Hematological abnormalities during the first week of life among neonates with Down syndrome: data from a multihospital healthcare system. Am J Med Genet A. 2007, 143A:42-50. 10.1002\/ajmg.a.31442","journal-title":"Am J Med Genet A"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-118810","article-title":"Treatment and prognostic impact of transient leukemia in neonates with Down syndrome","volume":"111","author":"Klusmann JH","year":"2008","unstructured":"Klusmann JH, Creutzig U, Zimmermann M, et al.. Treatment and prognostic impact of transient leukemia in neonates with Down syndrome. Blood. 2008, 111:2991-8. 10.1182\/blood-2007-10-118810","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-06-2448","article-title":"A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481","volume":"107","author":"Massey GV","year":"2006","unstructured":"Massey GV, Zipursky A, Chang MN, et al.. A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481. Blood. 2006, 107:4606-13. 10.1182\/blood-2005-06-2448","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-016-0338-x","article-title":"Transient abnormal myelopoiesis and AML in Down syndrome: an update","volume":"11","author":"Bhatnagar N","year":"2016","unstructured":"Bhatnagar N, Nizery L, Tunstall O, Vyas P, Roberts I. Transient abnormal myelopoiesis and AML in Down syndrome: an update. Curr Hematol Malig Rep. 2016, 11:333-41. 10.1007\/s11899-016-0338-x","journal-title":"Curr Hematol Malig Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-350017","article-title":"Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971","volume":"118","author":"Gamis AS","year":"2011","unstructured":"Gamis AS, Alonzo TA, Gerbing RB, et al.. Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971. Blood. 2011, 118:6752-9; quiz 6996. 10.1182\/blood-2011-04-350017","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.1311.1311","article-title":"Prospective study of 168 infants with transient abnormal myelopoiesis with Down syndrome: Japan Pediatric Leukemia\/Lymphoma Study Group, TAM-10 study","volume":"3","author":"Muramatsu H","year":"2015","unstructured":"Muramatsu H, Watanabe T, Hasegawa D, et al.. Prospective study of 168 infants with transient abnormal myelopoiesis with Down syndrome: Japan Pediatric Leukemia\/Lymphoma Study Group, TAM-10 study. Blood. 2015, 3:1311. 10.1182\/blood.V126.23.1311.1311","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/225266-transient-abnormal-myelopoiesis-an-abnormal-course-and-the-efficacy-of-delayed-treatment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T06:43:40Z","timestamp":1707979420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/225266-transient-abnormal-myelopoiesis-an-abnormal-course-and-the-efficacy-of-delayed-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,14]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.54219","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,14]]}}}